Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing recurrence of endometriosis with long-acting progestogen therapy after laparoscopy
ISRCTN97865475Phase 4Completed
- Sponsor
- NHS Grampian
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of medroxyprogesterone acetate and avatrombopag in endometriosis (3 arms), sponsored by NHS Grampian. Primary endpoint: Recurrence of symptoms. Started May 2014; status: completed.
02
Drugs
medroxyprogesterone acetateavatrombopag
03
Conditions
endometriosis
Beyond the preview
Go deeper on ISRCTN97865475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN97865475.